![]() ![]() BTIG hosted events are intended for prospective and existing BTIG clients only. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that Company’s management will participate in one-on-one investor meetings at the BTIG Biotechnology Conference 2022, to be held virtually and in New York City from August 8-9, 2022. 04, 2022 (GLOBE NEWSWIRE) - Synthetic Biologics, Inc. Synthetic Biologics to Participate in the BTIG Biotechnology Conference 2022 (NYSE American: SYN), a diversified clinical-stage company developing therapeutics desig 11, 2022 (GLOBE NEWSWIRE) - Synthetic Biologics, Inc. Prioritizing the advancement of novel oncolytic adenovirus (OV) platform-Cash balance as of Augof $53.5 million, including the additional $3 million in gross proceeds from convertible preferred financing extends funding for business operations into Q1 2024-Conference call and webcast to be held today at 8:30 a.m. ![]() Synthetic Biologics Reports Second Quarter 2022 Operational Highlights and Financial Results (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced a presentation of initial data from a Phase 1 investigator-sponsored study evaluating VCN-01 in combination with durvalumab for patient 05, 2022 (GLOBE NEWSWIRE) - Synthetic Biologics, Inc. Treatment with VCN-01 in combination with durvalumab demonstrated an acceptable safety profile and encouraging biological activity- ROCKVILLE, Md., Sept. Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck Below are the latest news stories about SYNTHETIC BIOLOGICS INC that investors may wish to consider to help them evaluate SYN as an investment opportunity. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |